Gene: RABAC1
Official Full Name: Rab acceptor 1provided by HGNC
Gene Summary: Enables identical protein binding activity. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03493 | RABAC1 Knockout cell line (HeLa) | Human | RABAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO03494 | RABAC1 Knockout cell line (HCT 116) | Human | RABAC1 | 1:2~1:4 | Negative | Online Inquiry |
KO03495 | RABAC1 Knockout cell line (HEK293) | Human | RABAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO03496 | RABAC1 Knockout cell line (A549) | Human | RABAC1 | 1:3~1:4 | Negative | Online Inquiry |
RABAC1 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the function of the RABAC1 gene. This gene is known to play a critical role in various cellular processes, including vesicular trafficking, membrane dynamics, and signal transduction pathways. The knockout of RABAC1 allows researchers to study the downstream effects and biological significance of this gene, providing insights into its functionality in health and disease.
The primary mechanism of action involves the use of CRISPR-Cas9 technology or other gene-editing methodologies that precisely target the RABAC1 locus, leading to an effective knockout. This targeted approach enables a clean disruption of the gene, allowing for clearer interpretation of experimental results. By utilizing these cell lines, researchers can explore the physiological roles of RABAC1 in various contexts, including cancer, neurodegenerative diseases, and metabolic disorders.
Scientifically, RABAC1 Gene Knockout Cell Lines are invaluable for both basic and applied research. They are applicable in drug discovery screens to identify new therapeutics aimed at modulating the pathways influenced by RABAC1. Moreover, they can be utilized in the development of gene therapies, allowing for in-depth studies of potential treatment modalities for diseases linked to RABAC1 dysregulation.
Compared to conventional cell lines, these knockout cell lines offer a unique advantage by permitting specific gene function analysis without redundant activities from the RABAC1 gene. This specificity results in higher experimental accuracy, ultimately leading to more reliable outcomes. Additionally, the availability of these cell lines contributes to standardization across experiments, facilitating reproducibility and comparability within research endeavors.
For researchers and clinicians alike, the RABAC1 Gene Knockout Cell Lines present a powerful tool in understanding gene function and exploring new therapeutic pathways. Investing in this product not only enhances research capabilities but also aligns with cutting-edge scientific practices aimed at unraveling the complexities of gene regulation.
At our company, we pride ourselves on our extensive experience in providing high-quality biological products and are committed to supporting the research community with innovative solutions like the RABAC1 Gene Knockout Cell Lines. Our expertise ensures that you receive reliable and effective tools for advancing your scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.